Systemic cytokine response in murine anthrax
暂无分享,去创建一个
Jay Wells | Charles L. Bailey | M. Maland | C. Bradburne | Jay B. Wells | K. Alibek | T. Popova | S. G. Popov | E. Grene | F. Klotz | Jennifer Cardwell | Y. Jama | A. Nalca | Tom Voss | Edith Grene | Ken Alibek | Serguei G. Popov | Taissia G. Popova | Francis Klotz | Jennifer Cardwell | Chris Bradburne | Yusuf Jama | Matthew Maland | Aysegul Nalca | Tom Voss | Charles Bailey | Aysegul Nalca
[1] Jerome Hauer,et al. Anthrax as a biological weapon, 2002: updated recommendations for management. , 2002, JAMA.
[2] L. Romics,et al. Liver in sepsis and systemic inflammatory response syndrome. , 2002, Clinics in liver disease.
[3] Charles L. Bailey,et al. Lethal toxin of Bacillus anthracis causes apoptosis of macrophages. , 2002, Biochemical and biophysical research communications.
[4] S. Welkos. Plasmid-associated virulence factors of non-toxigenic (pX01-) Bacillus anthracis. , 1991, Microbial pathogenesis.
[5] Cesare Montecucco,et al. Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNγ‐induced release of NO and TNFα , 1999 .
[6] L. F. Kolakowski,et al. Expression and biologic characterization of the murine chemokine KC. , 1995, Journal of immunology.
[7] S. Welkos,et al. Differences in susceptibility of inbred mice to Bacillus anthracis , 1986, Infection and immunity.
[8] Rafael Villasmil,et al. Effect of Bacillus anthracis lethal toxin on human peripheral blood mononuclear cells , 2002, FEBS letters.
[9] J. Patterson,et al. The Liver. An Atlas and Text of Ultrastructural Pathology , 1988 .
[10] S. Thorgeirsson,et al. Transient activation of NF-κB through a TAK1/IKK kinase pathway by TGF-β1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation , 2003, Oncogene.
[11] H. Smith,et al. The chemical basis of the virulence of Bacillus anthracis. V. The specific toxin produced by B. Anthracis in vivo. , 1955, British journal of experimental pathology.
[12] B. Bloom,et al. Role of Macrophage Oxidative Burst in the Action of Anthrax Lethal Toxin , 1994, Molecular medicine.
[13] A. Friedlander,et al. Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. , 1986, The Journal of biological chemistry.
[14] Michael Karin,et al. Macrophage Apoptosis by Anthrax Lethal Factor Through p38 MAP Kinase Inhibition , 2002, Science.
[15] J. Dhainaut,et al. Hepatic response to sepsis: Interaction between coagulation and inflammatory processes , 2001, Critical care medicine.
[16] S. Bavari,et al. Macrophage-Derived Cell Lines Do Not Express Proinflammatory Cytokines after Exposure to Bacillus anthracis Lethal Toxin , 2001, Infection and Immunity.
[17] M. Mock,et al. Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. , 2000, The Biochemical journal.
[18] C. Bellone,et al. ON A ROLE , 1996 .
[19] K D Paull,et al. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. , 1998, Science.
[20] D. Acosta,et al. On the role of macrophages in anthrax. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[21] M. Mock,et al. Lethal factor of Bacillus anthracis cleaves the N-terminus of MAPKKs: analysis of the intracellular consequences in macrophages. , 2000, International journal of medical microbiology : IJMM.
[22] M. Manns,et al. Mediators of inflammation and acute phase response in the liver. , 2001, Cellular and molecular biology.
[23] G. Cohen,et al. “Have You Seen This?” Diffuse Hepatic Apoptosis , 2001, Toxicologic pathology.
[24] S. Nagata,et al. Lethal effect of the anti-Fas antibody in mice , 1993, Nature.
[25] O. Yampolskaya,et al. Quantitative Pathology of Inhalational Anthrax I: Quantitative Microscopic Findings , 2001, Modern Pathology.
[26] C. Haslett,et al. AN APPETITE FOR APOPTOTIC CELLS? CONTROVERSIES AND CHALLENGES , 2000, British journal of haematology.
[27] G. Wanner,et al. Inhibition of caspase activity prevents CD95‐mediated hepatic microvascular perfusion failure and restores Kupffer cell clearance capacity , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] C. Haslett,et al. Phagocyte recognition of cells undergoing apoptosis. , 1993, Immunology today.
[29] F. Dallegri,et al. Tissue injury in neutrophilic inflammation , 1997, Inflammation Research.
[30] N. Van Rooijen,et al. Complementary Adhesion Molecules Promote Neutrophil- Kupffer Cell Interaction and the Elimination of Bacteria Taken Up by the Liver1 , 2002, The Journal of Immunology.
[31] T. Koehler,et al. Early Bacillus anthracis–macrophage interactions: intracellular survival and escape , 2000 .
[32] F. Dalldorf,et al. Capillary thrombosis as a cause of death in experimental anthrax. , 1967, Archives of pathology.
[33] G. Boivin,et al. Macrophage Apoptosis by Anthrax Lethal Factor Through p 38 MAP Kinase Inhibition , 2002 .
[34] S. Ju,et al. Fas Ligand Engagement of Resident Peritoneal Macrophages In Vivo Induces Apoptosis and the Production of Neutrophil Chemotactic Factors1 , 2001, The Journal of Immunology.
[35] E. Wing,et al. Neutrophil-Kupffer-cell interaction in host defenses to systemic infections. , 1998, Immunology today.
[36] N. Hayashi,et al. Interleukin 1beta protects mice from Fas-mediated hepatocyte apoptosis and death. , 1999, Gastroenterology.
[37] P. Hanna,et al. Biochemical and physiological changes induced by anthrax lethal toxin in J774 macrophage-like cells. , 1992, Molecular biology of the cell.
[38] J. Maher,et al. Anti-Fas Induces Hepatic Chemokines and Promotes Inflammation by an NF-κB-independent, Caspase-3-dependent Pathway* , 2001, The Journal of Biological Chemistry.
[39] S. de Jong,et al. Fas receptor‐mediated apoptosis: a clinical application? , 2002, The Journal of pathology.
[40] S. Gordon,et al. Recognizing death: the phagocytosis of apoptotic cells. , 1998, Trends in cell biology.